Stocks
Amylyx Pharmaceuticals (AMLX) Operating Income US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -82.7 | -201.3 | 38.8 | -314.7 | -153.3 | -159.3 | |||
| Changes by years, y/y, % | +112% | +143% | -119% | -911% | -51% | +31.5% | |||
Amylyx Pharmaceuticals. Operating Income, bln rub
Amylyx Pharmaceuticals. Operating Income, changes, %
Amylyx Pharmaceuticals. Operating Income, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) Operating Income US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Operating Income, bln rub | -37.8 | -42.9 | -36.0 | -36.6 | -43.8 | -159.3 | ||
| Changes by years, y/y, % | -69% | -20% | -52% | -10% | +16% | |||
| Changes by quarters, q/q, % | -7% | +13% | -16% | +2% | +20% | |||
